Multiple Companies Report Strategic Developments in Healthcare and Mining Sectors

Arecor Therapeutics PLC is advancing discussions for a broader partnership regarding its lead insulin candidate AT278, with a phase II trial expected in the latter half of 2026. Great Southern Copper PLC has expanded its La Colorada prospect in Chile through the acquisition of five additional concessions, increasing its total area to 1,000 hectares.

Powerhouse Energy Group PLC has entered a non-exclusive licensing agreement with Hydrogen Utopia International PLC for its waste-to-energy technology, establishing a presence in central Europe. Genflow Biosciences has secured an international patent for its SIRT6 protein targeting muscle-wasting diseases, enhancing its intellectual property portfolio. Gelion has reported significant progress in its sulfur battery technology and secured new funding.